Last checked at 9 Aug 2021 18:24
Ap19
FORM 8.3 Amendment to Purchases and Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | UDG HEALTHCARE PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 5 August 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
12,396,007 | 4.92% | 636,357 | 0.25% | ||
(2) | Derivatives (other than options): | ||||
141,935 | 0.06% | 9,499,914 | 3.77% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
(4) | TOTAL: | ||||
12,537,942 | 4.98% | 10,136,271 | 4.02% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit | |
| Purchase | 23 | 10.7908 GBP | |
| Purchase | 9,014 | 10.7700 GBP | |
| Purchase | 11,048 | 10.7896 GBP | |
| Purchase | 15,137 | 10.7773 GBP | |
| Purchase | 19,254 | 10.7845 GBP | |
| Purchase | 21,523 | 10.7807 GBP | |
| Purchase | 23,366 | 10.7815 GBP | |
| Purchase | 32,826 | 10.7800 GBP | |
| Purchase | 174,121 | 10.7750 GBP | |
| Purchase | 184,067 | 10.7900 GBP | |
| Purchase | 250,000 | 10.7782 GBP | |
| Purchase | 319,338 | 10.7891 GBP | |
| Sale | 922 | 10.7905 GBP | |
| Sale | 983 | 10.7695 GBP | |
| Sale | 1,688 | 10.7700 GBP | |
| Sale | 2,240 | 10.7817 GBP | |
| Sale | 52,884 | 10.7883 GBP | |
| Sale | 97,038 | 10.7750 GBP | |
| Sale | 111,843 | 10.7900 GBP | |
| (b) | Derivatives transactions (other than option transactions) | ||
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | |||
| CFD | Long | 983 | 10.7695 GBP |
| SWAP | Long | 1,934 | 10.7712 GBP |
| CFD | Long | 2,240 | 10.7817 GBP |
| CFD | Long | 5,100 | 10.7718 GBP |
| SWAP | Long | 5,711 | 10.7894 GBP |
| SWAP | Long | 56,643 | 10.7900 GBP |
| CFD | Short | 23 | 10.7908 GBP |
| CFD | Short | 24,056 | 10.7791 GBP |
| SWAP | Short | 33,702 | 10.7847 GBP |
| SWAP | Short | 130,059 | 10.7900 GBP |
| SWAP | Short | 260,837 | 10.7887 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure | 9 August 2021 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210809005657/en/
Copyright Business Wire 2021